What is KrossLinker?
Krosslinker, based in Singapore, is a developer of thermal insulating nano-materials specifically engineered for the pharmaceutical industry. The company's innovative materials are designed to enhance the stability and efficacy of temperature-sensitive pharmaceutical products during storage and transit, addressing a critical need for reliable cold chain solutions in a highly regulated market. The company's focus on nanotechnology positions it at the forefront of material science innovation.
How much funding has KrossLinker raised?
KrossLinker has raised a total of $1.3M across 1 funding round:
Angel/Seed
$1.3M
Angel/Seed (2020): $1.3M with participation from 500.com
Key Investors in KrossLinker
500.com
500.com Limited is a leading online sports lottery service provider in China, offering a comprehensive suite of services. Their involvement suggests an interest in diversified technology investments beyond their core operations.
What's next for KrossLinker?
With a major enterprise-level funding context, KrossLinker is poised for significant scaling and market penetration. The strategic investment suggests a strong belief in the company's technology and its potential to disrupt the pharmaceutical supply chain. Future endeavors will likely involve expanding production capabilities, forging strategic partnerships within the pharmaceutical and logistics sectors, and further research and development to broaden the application of their nano-material technology. This capital infusion is expected to accelerate their growth trajectory and solidify their market position.
See full KrossLinker company page
